Trial Profile

Surveillance for Rates of Pertussis Disease Among Persons Birth Through 59 Months of Age Receiving Pentacel or Other Pertussis Vaccines.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 17 Sep 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Hib-DTaP-poliovirus vaccine (Primary) ; DTaP vaccine
Indications Diphtheria; Haemophilus infections; Pertussis; Poliomyelitis; Tetanus
Focus Therapeutic Use
Sponsors Sanofi; Sanofi Pasteur

Most Recent Events

10 Sep 2020 Results published in the Vaccine
28 Jun 2017 Status changed from active, no longer recruiting to completed.
27 Mar 2015 Planned End Date changed from 1 Jun 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com